Re:Myocarditis after Covid vaccination: Research on possible...
by wrycoder on Monday November 14, 2022 @10:31AM
(#33595421)
As soon as the EUAs were issued, the vaccine manufacturers shut down clinical trial followup and, in many cases, allowed vaccination of the control branch of the trials. Same for Paxlovid, where support for independent trials was refused.
[ Parent
| on HN ]
Re:Myocarditis after Covid vaccination: Research on possible...
by throwaway049 on Monday November 14, 2022 @02:11PM
(#33599265)
'allowed vaccination of the control branch'
People in the control branch were told they were controls so that they had the option to get the newly-authorized vaccine for real. Standard practice for trials that go well.
Re:Myocarditis after Covid vaccination: Research on possible...
by wrycoder on Monday November 14, 2022 @05:58PM
(#33602590)
And so the long term effects of the treatment are uncontrolled.
I think it's standard practice for therapeutics, but not for vaccines?
Re:Myocarditis after Covid vaccination: Research on possible...
by pieter_mj on Monday November 14, 2022 @02:18PM
(#33599390)
I, probably with many others, didn't realize this could be the consequence of an EUA until you mentioned it here. Thank you.
Re:Myocarditis after Covid vaccination: Research on possible...
by snowwrestler on Monday November 14, 2022 @06:28PM
(#33602935)
It's not specific to EUA, this is commonly done when a Phase 3 trial shows a clear benefit. Essentially, once you're sure a medicine confers a real benefit, it becomes unethical to deny it to the control branch any longer.